1. Stocks
  2. Elicio Therapeutics Inc.
  3. Swot
swot-logo

Elicio Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Elicio Therapeutics Inc. has 21 Strengths, 5 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

MACD Crossover Above Signal Line

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

MACD crossed above signal line previous end of day

Increasing profits every quarter for the past 2 quarters

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Volume Shockers

Biggest Price Gainers from Open

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months